Home›US Markets›M&A & Deals›AstraZeneca shares fall on reported Bristol Myers merg…

AstraZeneca shares fall on reported Bristol Myers merger talks

CNBC says the companies have discussed a potential merger over several months, leaving some analysts uncertain about the rationale and timing.

Reported · Written up by our desk · M&A & Deals

AstraZeneca shares slid after reports emerged that the company has been in merger talks with Bristol Myers, prompting analyst questions.

CNBC said the two firms have discussed a potential deal over several months, according to the reporting.

The reports appear to have weighed on sentiment around AstraZeneca, with analysts described as perplexed by the situation.

More like this

Sources